These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 25918443

  • 1. Time for a change: addressing R&D and commercialization challenges for antibacterials.
    Payne DJ, Miller LF, Findlay D, Anderson J, Marks L.
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun 05; 370(1670):20140086. PubMed ID: 25918443
    [Abstract] [Full Text] [Related]

  • 2. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR, BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development.
    J Antimicrob Chemother; 2011 Sep 05; 66(9):1948-53. PubMed ID: 21700625
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Challenges and solutions for clinical development of new antibacterial agents: results of a survey among pharmaceutical industry professionals.
    Bettiol E, Wetherington JD, Schmitt N, Harbarth S, COMBACTE Consortium.
    Antimicrob Agents Chemother; 2015 Jul 05; 59(7):3695-9. PubMed ID: 25918147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Who will develop new antibacterial agents?
    Cole ST.
    Philos Trans R Soc Lond B Biol Sci; 2014 Jul 05; 369(1645):20130430. PubMed ID: 24821916
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic research and development: business as usual?
    Harbarth S, Theuretzbacher U, Hackett J, DRIVE-AB consortium.
    J Antimicrob Chemother; 2015 Jul 05; 70(6):1604-7. PubMed ID: 25673635
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The ABCs of the US Broad Spectrum Antimicrobials Program: Antibiotics, Biosecurity, and Congress.
    Billington JK.
    Health Secur; 2015 Jul 05; 13(6):349-54. PubMed ID: 26569379
    [Abstract] [Full Text] [Related]

  • 13. The millennium bugs--the need for and development of new antibacterials.
    Bax R, Mullan N, Verhoef J.
    Int J Antimicrob Agents; 2000 Sep 05; 16(1):51-9. PubMed ID: 11185414
    [Abstract] [Full Text] [Related]

  • 14. Resistance diagnosis and the changing economics of antibiotic discovery.
    McAdams D.
    Ann N Y Acad Sci; 2017 Jan 05; 1388(1):18-25. PubMed ID: 28072904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Economic Conundrum for Antibacterial Drugs.
    Shlaes DM.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31658969
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibacterial R&D incentives.
    Laxminarayan R, Powers JH.
    Nat Rev Drug Discov; 2011 Sep 30; 10(10):727-8. PubMed ID: 21959280
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.